tiprankstipranks
Trending News
More News >

Linical Reports Decline in Financial Performance for 2024

Story Highlights
Linical Reports Decline in Financial Performance for 2024

Don’t Miss TipRanks’ Half-Year Sale

Linical Co., Ltd. ( (JP:2183) ) has issued an update.

Linical Co., Ltd. reported a significant decline in its financial performance for the nine months ending December 31, 2024, with a 14% drop in net sales compared to the previous year. The company also faced operating and ordinary income losses, alongside a negative profit attributable to its owners, indicating a challenging economic environment and potentially impacting its market positioning and stakeholder confidence.

More about Linical Co., Ltd.

Linical Co., Ltd. is a company listed on the Tokyo Stock Exchange, focusing on providing comprehensive clinical research services. It operates in the healthcare and pharmaceutical industry, offering solutions that support the clinical development and regulatory approval processes.

Average Trading Volume: 48,225

Technical Sentiment Consensus Rating: Buy

Current Market Cap: Yen7.86B

Learn more about 2183 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1